ArticleCancer prevention research (Philadelphia, Pa.)2010

The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-KrasG12D/+ transgenic mouse model.

Altaf Mohammed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.